• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/15

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

15 Cards in this Set

  • Front
  • Back
Antiplatelet Drugs
Acetylsalicyclic Acid
P2Y12 Antags
PDE Inhibitors
GPIIb/IIIa Antags
Aspirin MOA
Inhibit TXA2 formation
Inhibit plt activation and agg
Aspirin Characteristics
Lack of response may be due to aspirin resistance

Extrinsic mech: INC platelet function due to exogenous substances (smoking), other NSAIDS, INC plt turnover, inadeq dosing

Intrinsic Mech: inducible COX2 activity, genetic polymorphism, production of TXA precursor, polymorphism GPIIb/IIIa Rc making plt less dep on TXA for activation
Aspirin PK
Rapid abs in stomach and upper stomach

Peak conc in 15-20 mins

Peak INHIBITORY eff: 1 hr post admin

IRREV INHIB of Cox... for the rest of the plt lifespan... 7 days
Aspirin Use
Secondary Prevention of TIA, ischemic stroke, and MI
Prevention of ischemic events in pts with angina

Prevention of CABG occlusion
Aspirin ADR/Limitations
Risk of GI events: ulceration and bleeding
Allergic rxn
Irreversible plt inhib

not very eff antithrombotic drug but widely used due to ease of use
ADP Receptor Antag
P2Y12
Clopidogrel
Ticlopidine
Prasugrel
Cangrelor
Ticagrelor
Clopidogrel MOA
Block ADP binding at ADP receps
Clopidogrel Characteristics
Combined with aspirin
Std prevention of MI in ACS and for thrombosis prevention after coronary stent and angioplasty

Resistance: Great inter-individual variation in response to abs and metab
Clopidogrel PK
Rapid abs after oral admin (>50%)
Parent drug and metabolites bind well to plasma prot (90%)
Prodrug: must be metab-ed in liver
Clopidogrel Use
Secondary prevention of ischemic complications after MI, ischemic stroke, and estab-ed peripheral arterial disease

Secondary prevention of ischemic complications in pts with ACS without ST segment elevation
Clopidogrel ADR/Limitations
Only slightly more eff than aspirin
More expensive

As with aspirin it binds irreversibly to plts
Ticlopidine MOA
Block ADP binding at ADP recep
Ticlopidine PK
similar to clopidogrel
food inc abs
Ticlopidine ADR/Limitations
Rare fatal ADRs
neutropenia and bone marrow aplasia
Less favorable adr profile than clopidogrel